Vivaldi Capital Management’s Indaptus Therapeutics INDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-857
| Closed | -$13.2K | – | 300 |
|
|
2025
Q1 | $13.2K | Hold |
857
| – | – | ﹤0.01% | 283 |
|
|
2024
Q4 | $22.2K | Hold |
857
| – | – | ﹤0.01% | 285 |
|
|
2024
Q3 | $29.8K | Hold |
857
| – | – | 0.01% | 225 |
|
|
2024
Q2 | $50.9K | Hold |
857
| – | – | 0.01% | 229 |
|
|
2024
Q1 | $51.6K | Hold |
857
| – | – | 0.02% | 220 |
|
|
2023
Q4 | $40K | Hold |
857
| – | – | 0.01% | 218 |
|
|
2023
Q3 | $66.1K | Hold |
857
| – | – | 0.02% | 191 |
|
|
2023
Q2 | $45.8K | Hold |
857
| – | – | 0.01% | 198 |
|
|
2023
Q1 | $44.4K | Hold |
857
| – | – | 0.01% | 199 |
|
|
2022
Q4 | $38.4K | Hold |
857
| – | – | 0.01% | 240 |
|
|
2022
Q3 | $48K | Hold |
857
| – | – | 0.01% | 219 |
|
|
2022
Q2 | $63K | Hold |
857
| – | – | 0.02% | 215 |
|
|
2022
Q1 | $60K | Buy |
+857
| New | +$60K | 0.02% | 212 |
|